Abridge vs Commure
If your failure mode is buying the enterprise scribe that does revenue cycle too without asking how each got there, this is the pair that separates organic depth from assembled breadth. Abridge built outward from a documentation core: the strongest evidence in the category, a Kaiser study of 1,306 clinicians in NEJM AI plus Best in KLAS in 2025 and 2026, the deepest Epic integration in the index with native bidirectional sync, and Linked Evidence that maps every generated sentence back to the source audio. Commure assembled the same surface area by acquisition, rolling up Athelas, Augmedix, and Memora into ambient documentation that flows into autonomous coding, CDI, and claims, with broad reach across 50 plus EHRs and explicit human review tiers. One earned the footprint and can prove it. The other bought the footprint and bundles it.
- The strongest evidence in the category: a Kaiser Permanente study of 1,306 clinicians published in NEJM AI, independently corroborated by Best in KLAS for Ambient AI in both 2025 and 2026, which is buyer survey based rather than vendor asserted.
- The deepest EHR integration in the index: embedded natively across Epic Haiku, Canto, and Hyperdrive with bidirectional note sync rather than a parallel interface, plus an athenahealth partnership and real time prior authorization.
- The most rigorous oversight in the category: Linked Evidence maps every part of a generated note back to the source audio, so a clinician can verify any sentence against what was actually said before signing.
- One vendor for the whole revenue cycle adjacent stack: Commure rolls up Athelas, Augmedix, and Memora so ambient documentation flows into autonomous coding, CDI, and claims under a single contract, with Vizient negotiated access for member systems.
- Human review built in as a product tier rather than an afterthought: Go is AI only, Assist adds specialist review, and Live is synchronous human documentation, so a buyer can dial the level of human involvement per use case.
- Broad EHR reach beyond Epic: Augmedix Go is documented across more than 50 systems including Oracle Health and MEDITECH, across ambulatory and acute settings.
Side-by-Side
| Axis | A Abridge |
C Commure |
|---|---|---|
| AI Centrality | ||
| Autonomy and Oversight Model | ||
| Model and Technology Transparency | — | — |
| Clinical and Operational Evidence | — | |
| AI Safety and PHI Stewardship | — | |
| HIPAA and BAA Posture | — | |
| Security Certifications and Trust Center | — | |
| FDA and Regulatory Status | — | — |
| AI Governance and Bias Disclosure | — | — |
| EHR and Interoperability Depth | ||
| Deployment Model and Data Residency | — | |
| Commercial Transparency | ||
| Setting and Specialty Coverage |
The two are assessed to different depth, so read the grades accordingly. Abridge carries A across its assessed axes (AI centrality, evidence, autonomy, EHR, setting); Commure sits at B across security, HIPAA, PHI, EHR, setting, and autonomy and has no clinical evidence axis graded, so its documentation evidence is unassessed here rather than weak. Neither publishes pricing; both are contact the vendor, with a third party estimate of roughly 2,500 dollars per clinician per year recorded for Abridge. Commure's SOC 2 Type 2 reference attaches to its data centers rather than to Commure itself, and its PHI language does not state whether data trains models. As with every ambient scribe, speech models carry documented accuracy variation across accent and dialect.